<DOC>
	<DOC>NCT01089582</DOC>
	<brief_summary>This study assessed the Hr QoL (Health related Quality of life) of subjects with mild to moderate AD, who received ARICEPT under usual clinical practice.</brief_summary>
	<brief_title>Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets</brief_title>
	<detailed_description>This non-interventional study enrolled patients with mild to moderate dementia of the Alzheimer's type, who have been prescribed treatment with ARICEPT under usual clinical practice.</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Diagnosis of Alzheimer's Disease There are no exclusion criteria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>non-interventional</keyword>
	<keyword>mild to moderate Alzheimer's</keyword>
	<keyword>ARICEPT.</keyword>
</DOC>